home / stock / aitb / aitb news

AITB News and Press, AIT Therapeutics Inc

Stock Information
Company Name: AIT Therapeutics Inc
Stock Symbol: AITB
Market: OTC
Menu
AITB AITB Quote AITB Short AITB News AITB Articles AITB Message Board
Get AITB Alerts

News, Short Squeeze, Breakout and More Instantly...
AITB - CORRECTING and REPLACING - AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results

Announces name change to  Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar 2020 Announced licensing agreement ...
AITB - AIT Therapeutics beats on revenue

AIT Therapeutics (NASDAQ: AITB ): Q4 GAAP EPS of -$0.49. More news on: AIT Therapeutics, Inc., Earnings news and commentary, Tech stocks news, , Read more ...

AITB - AIT Therapeutics Reports Financial Results for Fiscal Fourth Quarter and Year-End 2019 Results

Announces name change to   Beyond Air™ Completed uplisting to the NASDAQ and $7.96 million PIPE financing Anticipate PMA submission in the third quarter of calendar 2019 Anticipate CE Mark in the first half of calendar 2020 Announced licensing agreeme...

AITB - AIT Therapeutics Schedules Fiscal Year 2019 Financial Results Conference Call and Webcast

GARDEN CITY, N.Y. and REHOVOT, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including s...
AITB - AIT Therapeutics Announces $8 Million PIPE Financing

GARDEN CITY, N.Y. and REHOVOT, Israel, June 04, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including s...

AITB - AIT Therapeutics to Participate at Jefferies 2019 Global Healthcare Conference

GARDEN CITY, N.Y. and REHOVOT, Israel, June 03, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including s...

AITB - AIT Therapeutics Announces Study Published in Journal of Cystic Fibrosis

GARDEN CITY, N.Y. and REHOVOT, Israel, May 29, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including se...
AITB - AIT Therapeutics Presents On-Demand Nitric Oxide Study and Poster at the International Society for Aerosols in Medicine 2019 Congress in Montreux, Switzerland

GARDEN CITY, N.Y. and REHOVOT, Israel, May 28, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including se...

AITB - Walmart's 5260, Computex And Healthcare Headwinds (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you can re...

AITB - Stocks To Watch: Walmart's 5260, Computex And Healthcare Headwinds

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. No formal trade talks are scheduled between the U.S. and China, but President Trump...
Next 10